Met-RANTES (human)
| Name | Met-RANTES (human) |
| Category | Chemokines and Cytokines |
| One Letter Code | MSPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS (Disulfide bridge: 11 - 35, 12 - 51) |
| Three Letter Code | {Met}{Ser}{Pro}{Tyr}{Ser}{Ser}{Asp}{Thr}{Thr}{Pro}{Cys}{Cys}{Phe}{Ala}{Tyr}{Ile}{Ala}{Arg}{Pro}{Leu}{Pro}{Arg}{Ala}{His}{Ile}{Lys}{Glu}{Tyr}{Phe}{Tyr}{Thr}{Ser}{Gly}{Lys}{Cys}{Ser}{Asn}{Pro}{Ala}{Val}{Val}{Phe}{Val}{Thr}{Arg}{Lys}{Asn}{Arg}{Gln}{Val}{Cys}{Ala}{Asn}{Pro}{Glu}{Lys}{Lys}{Trp}{Val}{Arg}{Glu}{Tyr}{Ile}{Asn}{Ser}{Leu}{Glu}{Met}{Ser} (Disulfide bridge: 11-35, 12-51) (Disulfide bridge: 11 - 35, 12 - 51) |
| Molecular Weight | 7978.210 |
| Application | Cytokines/Chemokines & their ReceptorsRegenerative Medicine |
| Proudfoot, Amanda EI, et al. "Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist." Journal of Biological Chemistry271.5 (1996): 2599-2603. |